The Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization are attempting to use the generic lobby’s recent legal victory against Maryland's price-gouging law to boost their efforts to block a drug-pricing law in Nevada. PhRMA is taking a similar tact in California.